Page last updated: 2024-08-22

hyaluronoglucosaminidase and Carcinoma, Small Cell

hyaluronoglucosaminidase has been researched along with Carcinoma, Small Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Danilkovitch-Miagkova, A; Duh, FM; Lerman, MI; Miller, AD; Rai, SK; Vigdorovich, V1

Other Studies

1 other study(ies) available for hyaluronoglucosaminidase and Carcinoma, Small Cell

ArticleYear
Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation.
    Proceedings of the National Academy of Sciences of the United States of America, 2001, Apr-10, Volume: 98, Issue:8

    Topics: Carcinoma, Small Cell; Cell Transformation, Neoplastic; Cell Transformation, Viral; Genes, env; Genes, Tumor Suppressor; Glycosylphosphatidylinositols; Humans; Hyaluronoglucosaminidase; Jaagsiekte sheep retrovirus; Lung Neoplasms; Membrane Fusion; Phosphatidylinositol Diacylglycerol-Lyase; Tumor Cells, Cultured; Type C Phospholipases

2001